Nausea And Vomiting Treatment Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Serotonin Receptor Antagonist
1.2.3 Neurokinin NK1 Receptor Antagonist
1.2.4 Others
1.3 Market by Application
1.3.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 CINV
1.3.3 PONV
1.3.4 Motion Sickness
1.3.5 Pregnancy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nausea And Vomiting Treatment Market Perspective (2017-2028)
2.2 Nausea And Vomiting Treatment Growth Trends by Region
2.2.1 Nausea And Vomiting Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nausea And Vomiting Treatment Historic Market Size by Region (2017-2022)
2.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Region (2023-2028)
2.3 Nausea And Vomiting Treatment Market Dynamics
2.3.1 Nausea And Vomiting Treatment Industry Trends
2.3.2 Nausea And Vomiting Treatment Market Drivers
2.3.3 Nausea And Vomiting Treatment Market Challenges
2.3.4 Nausea And Vomiting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nausea And Vomiting Treatment Players by Revenue
3.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2017-2022)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nausea And Vomiting Treatment Revenue
3.4 Global Nausea And Vomiting Treatment Market Concentration Ratio
3.4.1 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nausea And Vomiting Treatment Revenue in 2021
3.5 Nausea And Vomiting Treatment Key Players Head office and Area Served
3.6 Key Players Nausea And Vomiting Treatment Product Solution and Service
3.7 Date of Enter into Nausea And Vomiting Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nausea And Vomiting Treatment Breakdown Data by Type
4.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2017-2022)
4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2023-2028)
5 Nausea And Vomiting Treatment Breakdown Data by Application
5.1 Global Nausea And Vomiting Treatment Historic Market Size by Application (2017-2022)
5.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nausea And Vomiting Treatment Market Size (2017-2028)
6.2 North America Nausea And Vomiting Treatment Market Size by Type
6.2.1 North America Nausea And Vomiting Treatment Market Size by Type (2017-2022)
6.2.2 North America Nausea And Vomiting Treatment Market Size by Type (2023-2028)
6.2.3 North America Nausea And Vomiting Treatment Market Share by Type (2017-2028)
6.3 North America Nausea And Vomiting Treatment Market Size by Application
6.3.1 North America Nausea And Vomiting Treatment Market Size by Application (2017-2022)
6.3.2 North America Nausea And Vomiting Treatment Market Size by Application (2023-2028)
6.3.3 North America Nausea And Vomiting Treatment Market Share by Application (2017-2028)
6.4 North America Nausea And Vomiting Treatment Market Size by Country
6.4.1 North America Nausea And Vomiting Treatment Market Size by Country (2017-2022)
6.4.2 North America Nausea And Vomiting Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Nausea And Vomiting Treatment Market Size (2017-2028)
7.2 Europe Nausea And Vomiting Treatment Market Size by Type
7.2.1 Europe Nausea And Vomiting Treatment Market Size by Type (2017-2022)
7.2.2 Europe Nausea And Vomiting Treatment Market Size by Type (2023-2028)
7.2.3 Europe Nausea And Vomiting Treatment Market Share by Type (2017-2028)
7.3 Europe Nausea And Vomiting Treatment Market Size by Application
7.3.1 Europe Nausea And Vomiting Treatment Market Size by Application (2017-2022)
7.3.2 Europe Nausea And Vomiting Treatment Market Size by Application (2023-2028)
7.3.3 Europe Nausea And Vomiting Treatment Market Share by Application (2017-2028)
7.4 Europe Nausea And Vomiting Treatment Market Size by Country
7.4.1 Europe Nausea And Vomiting Treatment Market Size by Country (2017-2022)
7.4.2 Europe Nausea And Vomiting Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nausea And Vomiting Treatment Market Size (2017-2028)
8.2 Asia-Pacific Nausea And Vomiting Treatment Market Size by Type
8.2.1 Asia-Pacific Nausea And Vomiting Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nausea And Vomiting Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nausea And Vomiting Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Nausea And Vomiting Treatment Market Size by Application
8.3.1 Asia-Pacific Nausea And Vomiting Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nausea And Vomiting Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nausea And Vomiting Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region
8.4.1 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nausea And Vomiting Treatment Market Size (2017-2028)
9.2 Latin America Nausea And Vomiting Treatment Market Size by Type
9.2.1 Latin America Nausea And Vomiting Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Nausea And Vomiting Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Nausea And Vomiting Treatment Market Share by Type (2017-2028)
9.3 Latin America Nausea And Vomiting Treatment Market Size by Application
9.3.1 Latin America Nausea And Vomiting Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Nausea And Vomiting Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Nausea And Vomiting Treatment Market Share by Application (2017-2028)
9.4 Latin America Nausea And Vomiting Treatment Market Size by Country
9.4.1 Latin America Nausea And Vomiting Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Nausea And Vomiting Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nausea And Vomiting Treatment Market Size (2017-2028)
10.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Type
10.2.1 Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nausea And Vomiting Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Application
10.3.1 Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nausea And Vomiting Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country
10.4.1 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Details
11.1.2 Merck & Co. Inc. Business Overview
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction
11.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.1.5 Merck & Co. Inc. Recent Developments
11.2 Helsinn Group
11.2.1 Helsinn Group Company Details
11.2.2 Helsinn Group Business Overview
11.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction
11.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.2.5 Helsinn Group Recent Developments
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Details
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Details
11.4.2 Kyowa Kirin Business Overview
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction
11.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.4.5 Kyowa Kirin Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Nausea And Vomiting Treatment Introduction
11.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Details
11.6.2 Qilu Pharma Business Overview
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction
11.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.6.5 Qilu Pharma Recent Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Details
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.8 Taiji group
11.8.1 Taiji group Company Details
11.8.2 Taiji group Business Overview
11.8.3 Taiji group Nausea And Vomiting Treatment Introduction
11.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.8.5 Taiji group Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Nausea And Vomiting Treatment Introduction
11.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.9.5 Novartis Recent Developments
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Details
11.10.2 Heron Therapeutics Business Overview
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction
11.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.10.5 Heron Therapeutics Recent Developments
11.11 Atnahs Pharma UK Limited
11.11.1 Atnahs Pharma UK Limited Company Details
11.11.2 Atnahs Pharma UK Limited Business Overview
11.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Introduction
11.11.4 Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.11.5 Atnahs Pharma UK Limited Recent Developments
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Nausea And Vomiting Treatment Introduction
11.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.12.5 Mylan Recent Developments
11.13 Duchesnay
11.13.1 Duchesnay Company Details
11.13.2 Duchesnay Business Overview
11.13.3 Duchesnay Nausea And Vomiting Treatment Introduction
11.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.13.5 Duchesnay Recent Developments
11.14 Tesaro
11.14.1 Tesaro Company Details
11.14.2 Tesaro Business Overview
11.14.3 Tesaro Nausea And Vomiting Treatment Introduction
11.14.4 Tesaro Revenue in Nausea And Vomiting Treatment Business (2017-2022)
11.14.5 Tesaro Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nausea And Vomiting Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Serotonin Receptor Antagonist
Table 3. Key Players of Neurokinin NK1 Receptor Antagonist
Table 4. Key Players of Others
Table 5. Global Nausea And Vomiting Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Nausea And Vomiting Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Nausea And Vomiting Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Nausea And Vomiting Treatment Market Share by Region (2017-2022)
Table 9. Global Nausea And Vomiting Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Nausea And Vomiting Treatment Market Share by Region (2023-2028)
Table 11. Nausea And Vomiting Treatment Market Trends
Table 12. Nausea And Vomiting Treatment Market Drivers
Table 13. Nausea And Vomiting Treatment Market Challenges
Table 14. Nausea And Vomiting Treatment Market Restraints
Table 15. Global Nausea And Vomiting Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Nausea And Vomiting Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Nausea And Vomiting Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2021)
Table 18. Ranking of Global Top Nausea And Vomiting Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Nausea And Vomiting Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nausea And Vomiting Treatment Product Solution and Service
Table 22. Date of Enter into Nausea And Vomiting Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nausea And Vomiting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Nausea And Vomiting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Nausea And Vomiting Treatment Revenue Share by Application (2017-2022)
Table 30. Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Nausea And Vomiting Treatment Revenue Share by Application (2023-2028)
Table 32. North America Nausea And Vomiting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Nausea And Vomiting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Nausea And Vomiting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Nausea And Vomiting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Nausea And Vomiting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Nausea And Vomiting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Nausea And Vomiting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Nausea And Vomiting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Nausea And Vomiting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Nausea And Vomiting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Nausea And Vomiting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Nausea And Vomiting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Nausea And Vomiting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Nausea And Vomiting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Nausea And Vomiting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Nausea And Vomiting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Nausea And Vomiting Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Nausea And Vomiting Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Nausea And Vomiting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Nausea And Vomiting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Nausea And Vomiting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Nausea And Vomiting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Nausea And Vomiting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Nausea And Vomiting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Nausea And Vomiting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Nausea And Vomiting Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Nausea And Vomiting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Nausea And Vomiting Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Nausea And Vomiting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Nausea And Vomiting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Merck & Co. Inc. Company Details
Table 63. Merck & Co. Inc. Business Overview
Table 64. Merck & Co. Inc. Nausea And Vomiting Treatment Product
Table 65. Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 66. Merck & Co. Inc. Recent Developments
Table 67. Helsinn Group Company Details
Table 68. Helsinn Group Business Overview
Table 69. Helsinn Group Nausea And Vomiting Treatment Product
Table 70. Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 71. Helsinn Group Recent Developments
Table 72. Unimed Pharmaceuticals (AbbVie Inc.) Company Details
Table 73. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
Table 74. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product
Table 75. Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 76. Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments
Table 77. Kyowa Kirin Company Details
Table 78. Kyowa Kirin Business Overview
Table 79. Kyowa Kirin Nausea And Vomiting Treatment Product
Table 80. Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 81. Kyowa Kirin Recent Developments
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Nausea And Vomiting Treatment Product
Table 85. Sanofi Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 86. Sanofi Recent Developments
Table 87. Qilu Pharma Company Details
Table 88. Qilu Pharma Business Overview
Table 89. Qilu Pharma Nausea And Vomiting Treatment Product
Table 90. Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 91. Qilu Pharma Recent Developments
Table 92. Teva Pharmaceutical Industries Ltd. Company Details
Table 93. Teva Pharmaceutical Industries Ltd. Business Overview
Table 94. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product
Table 95. Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 97. Taiji group Company Details
Table 98. Taiji group Business Overview
Table 99. Taiji group Nausea And Vomiting Treatment Product
Table 100. Taiji group Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 101. Taiji group Recent Developments
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Nausea And Vomiting Treatment Product
Table 105. Novartis Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 106. Novartis Recent Developments
Table 107. Heron Therapeutics Company Details
Table 108. Heron Therapeutics Business Overview
Table 109. Heron Therapeutics Nausea And Vomiting Treatment Product
Table 110. Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 111. Heron Therapeutics Recent Developments
Table 112. Atnahs Pharma UK Limited Company Details
Table 113. Atnahs Pharma UK Limited Business Overview
Table 114. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product
Table 115. Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 116. Atnahs Pharma UK Limited Recent Developments
Table 117. Mylan Company Details
Table 118. Mylan Business Overview
Table 119. Mylan Nausea And Vomiting Treatment Product
Table 120. Mylan Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 121. Mylan Recent Developments
Table 122. Duchesnay Company Details
Table 123. Duchesnay Business Overview
Table 124. Duchesnay Nausea And Vomiting Treatment Product
Table 125. Duchesnay Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 126. Duchesnay Recent Developments
Table 127. Tesaro Company Details
Table 128. Tesaro Business Overview
Table 129. Tesaro Nausea And Vomiting Treatment Product
Table 130. Tesaro Revenue in Nausea And Vomiting Treatment Business (2017-2022) & (US$ Million)
Table 131. Tesaro Recent Developments
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nausea And Vomiting Treatment Market Share by Type: 2021 VS 2028
Figure 2. Serotonin Receptor Antagonist Features
Figure 3. Neurokinin NK1 Receptor Antagonist Features
Figure 4. Others Features
Figure 5. Global Nausea And Vomiting Treatment Market Share by Application: 2021 VS 2028
Figure 6. CINV Case Studies
Figure 7. PONV Case Studies
Figure 8. Motion Sickness Case Studies
Figure 9. Pregnancy Case Studies
Figure 10. Others Case Studies
Figure 11. Nausea And Vomiting Treatment Report Years Considered
Figure 12. Global Nausea And Vomiting Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Nausea And Vomiting Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Nausea And Vomiting Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Nausea And Vomiting Treatment Market Share by Players in 2021
Figure 16. Global Top Nausea And Vomiting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Nausea And Vomiting Treatment Revenue in 2021
Figure 18. North America Nausea And Vomiting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Nausea And Vomiting Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Nausea And Vomiting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Nausea And Vomiting Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Nausea And Vomiting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Nausea And Vomiting Treatment Market Size Share by Region (2017-2028)
Figure 38. China Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Nausea And Vomiting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Nausea And Vomiting Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Nausea And Vomiting Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Nausea And Vomiting Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Nausea And Vomiting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Merck & Co. Inc. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 58. Helsinn Group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 59. Unimed Pharmaceuticals (AbbVie Inc.) Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 60. Kyowa Kirin Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 61. Sanofi Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 62. Qilu Pharma Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 64. Taiji group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 65. Novartis Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 66. Heron Therapeutics Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 67. Atnahs Pharma UK Limited Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 68. Mylan Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 69. Duchesnay Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 70. Tesaro Revenue Growth Rate in Nausea And Vomiting Treatment Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed